Cargando…
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. We have previously shown that human MSCs (hMSCs) decrease inflammation and infection in the in vivo murine model of CF. The studies in this p...
Autores principales: | Sutton, Morgan T., Fletcher, David, Ghosh, Santosh K., Weinberg, Aaron, van Heeckeren, Rolf, Kaur, Sukhmani, Sadeghi, Zhina, Hijaz, Adonis, Reese, Jane, Lazarus, Hillard M., Lennon, Donald P., Caplan, Arnold I., Bonfield, Tracey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746399/ https://www.ncbi.nlm.nih.gov/pubmed/26925108 http://dx.doi.org/10.1155/2016/5303048 |
Ejemplares similares
-
Enhancing Cystic Fibrosis Immune Regulation
por: van Heeckeren, Anna M., et al.
Publicado: (2021) -
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)
por: Bonfield, Tracey L., et al.
Publicado: (2023) -
Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes
por: Breitman, Maya, et al.
Publicado: (2021) -
Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020) -
Defining human mesenchymal stem cell efficacy in vivo
por: Bonfield, Tracey L, et al.
Publicado: (2010)